Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications—An Observational, Retrospective Study

Author:

Cappelli Sara12,Casto Elisabetta12,Lomi Marta12,Pagano Alessandra12,Gabbrielli Luciano2,Pancani Roberta2ORCID,Aquilini Ferruccio3,Gemignani Giulia3,Carrozzi Laura12,Celi Alessandro12ORCID

Affiliation:

1. Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy

2. Pneumology Unit, Pisa University Hospital, 56126 Pisa, Italy

3. OU Organization of Hospital Services, Pisa University Hospital, 56126 Pisa, Italy

Abstract

Background: COVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear. Patients and methods: This is a retrospective, single-center study including a population of consecutive patients admitted to the University Hospital of Cisanello (Pisa) from March 2020 to January 2021 with a positive SARS-CoV-2 nasopharyngeal swab and SARS-CoV-2-related pneumonia. The patients were divided into two populations based on the presence (n = 150) or absence (n = 515) of pleural effusion on chest CT scan, excluding patients with pre-existing pleural effusion. We collected laboratory data (hemoglobin, leukocytes, platelets, C-reactive protein, procalcitonin), worst PaO2/FiO2 ratio as an index of respiratory gas exchange impairment, the extent of interstitial involvement related to SARS-CoV-2 pneumonia and data on intensity of care, length of stay and outcome (discharge or death). Results: The prevalence of pleural effusion was 23%. Patients with pleural effusion showed worse gas exchange (p < 0.001), longer average hospital stay (p < 0.001), need for more health care resources (p < 0.001) and higher mortality (p < 0.001) compared to patients without pleural effusion. By multivariate analysis, pleural effusion was found to be an independent negative prognostic factor compared with other variables such as increased C-reactive protein, greater extent of pneumonia and older age. Pleural effusion was present at the first CT scan in most patients (68%). Conclusions: Pleural effusion associated with SARS-CoV-2 pneumonia is a relatively frequent finding that is confirmed to be a negative prognostic factor. Identifying early prognostic factors in an endemic-prone disease such as COVID-19 is necessary to optimize its clinical management. Further clinical studies aimed at better characterizing pleural effusion in these patients will be appropriate in order to clarify its pathogenetic role.

Publisher

MDPI AG

Subject

General Medicine

Reference20 articles.

1. (2022, December 23). World Health Organization Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&gclid=Cj0KCQiAnsqdBhCGARIsAAyjYjRiYHlcIwB5-BsDuCNNvepTbgsYe6vTejgdS6Pvb8--C5WvOKletNoaAl0FEALw_wcB.

2. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Hu;J. Clin. Virol.,2020

3. COVID-19 and Multiorgan Response;Zaim;Curr. Probl. Cardiol.,2020

4. A systematic review on recent trends in transmission, diagnosis, prevention and imaging features of COVID-19;Manigandan;Process Biochem.,2020

5. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): A pictorial review;Ye;Eur. Radiol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3